C07K 16/1282
Clostridium
Official title: Clostridium (G)
C07K16/1282 (Clostridium) appears on 369 US grants and 539 published applications in this corpus.
Search patents in C07K- Granted patents
- 369
- Published applications
- 539
- Assignees
- 227
- Inventors
- 749
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 7 | 0 |
| 2001 | 5 | 1 |
| 2002 | 3 | 6 |
| 2003 | 7 | 13 |
| 2004 | 6 | 21 |
| 2005 | 4 | 13 |
| 2006 | 2 | 4 |
| 2007 | 2 | 13 |
| 2008 | 6 | 14 |
| 2009 | 10 | 14 |
| 2010 | 7 | 20 |
| 2011 | 9 | 21 |
| 2012 | 10 | 35 |
| 2013 | 27 | 27 |
| 2014 | 22 | 30 |
| 2015 | 16 | 31 |
| 2016 | 28 | 33 |
| 2017 | 22 | 27 |
| 2018 | 22 | 31 |
| 2019 | 14 | 21 |
| 2020 | 22 | 33 |
| 2021 | 17 | 29 |
| 2022 | 20 | 20 |
| 2023 | 12 | 20 |
| 2024 | 19 | 24 |
| 2025 | 13 | 23 |
| 2026 | 8 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- RNA encoding an antibody29 Sep 2026US 12,747,451 B2Cure Vac SE
- Clostridium difficile antigens25 Aug 2026US 12,714,742 B2MicroPharm Limited
- Antibody for tetanus toxin and use thereof9 Jun 2026US 12,649,777 B2Beijing Wisdomab Biotechnology Co., Ltd
- Device, procedure and system for detecting bacterial pathogens including methicillin-resistant Staphylococcus aureus or clostridium difficile26 May 2026US 12,638,414 B2
- Genetically modified Lactobacillus and uses thereof14 Apr 2026US 12,599,637 B2BiomEdit, Inc.
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Methods of classifying and treating inflammatory bowel disease17 Sep 2026US 2026/0275426 A1Baylor College of Medicine
- Methods and means for the production of ig-like molecules20 Aug 2026US 2026/0242840 A1Merus N.V.
- Methods of treating and preventing clostridioides difficile using a recombinant fusion protein vaccine containing flic and flid30 Jul 2026US 2026/0216308 A1University of South Florida
Most cited
By later US patents
- Method of making transgenic mice lacking endogenous heavy chains1,057US 5,939,598 AAbgenix, Inc. · 1999
- Human antibodies derived from immunized xenomice1,057US 6,075,181 AAbgenix, Inc. · 2000
- Human antibodies derived from immunized xenomice943US 6,150,584 AAbgenix, Inc. · 2000
- Generation of xenogeneic antibodies639US 6,114,598 AAbgenix, Inc. · 2000
- Generation of Xenogenetic antibodies561US 6,162,963 AAbgenix, Inc. · 2000